Search

A tumor-targeting fluorescent probe has attracted increasing interest in fluorescent imaging for the noninvasive detection of cancers in recent years. Sulfonamide-containing naphthalimide derivatives (SN-2NI, SD-NI) were synthesized by the incorporation of N-butyl-4-ethyldiamino-1,8-naphthalene imide (NI) into sulfonamide (SN) and sulfadiazine (SD) as the tumor-targeting groups, respectively. These derivatives were further characterized by mass spectrometry (MS), nuclear magnetic resonance spectroscopy (1H NMR), Fourier transform infrared spectroscopy (FT-IR), ultraviolet–visible spectroscopy (UV), and a fluorescence assay. In vitro properties, including cell cytotoxicity and the cell uptake of tumor cells, were also evaluated. Sulfonamide-containing naphthalimide derivatives possessed low cell cytotoxicity to B16F10 melanoma cells. Moreover, SN-2NI and SD-NI can be taken up highly by B16F10 cells and then achieve good green fluorescent images in B16F10 cells. Therefore, sulfonamide-containing naphthalimide derivatives can be considered to be the potential probes used to target fluorescent imaging in tumors. [ABSTRACT FROM AUTHOR]

The article presents information on a study which described the preparation and copolymerization of six-membered cyclic carbonate monomers like 2-phenyl-5,5-bis(hydroxymethyl) trimethylene carbonate (PTC) and 5,5-dimethyl trimethylene carbonate (DTC). A review of the related literature is given. Methods utilized include Fourier transform infrared and ultraviolet, among others, while tin(II) 2-ethylhexanoate and aluminum isopropoxide were used as initiators. It discusses the research findings.